Posted on: 01/07/2020 17:21
“The US has bought virtually all stocks for the next three months of one of the two drugs that have proven to work against Covid-19, leaving practically nothing to the United Kingdom, Europe or most of the rest of the world. “According to the British newspaper ‘The Guardian’, according to which the US move has alarmed experts and associations. “They had access to most of the stocks of” Remdesivir “and therefore there is nothing for Europe“says Andrew Hill, Liverpool University’s senior visiting reserach fellow.
Remdesivir is the first drug approved by regulatory authorities in the United States to treat Covid-19, it is produced by Gilead and has proven useful in helping people heal faster from Covid-19. “The first 140,000 doses, supplied for drug trials worldwide, have been exhausted – reports the newspaper – and the Trump administration has now purchased over 500,000 doses, which is all of Gilead’s production for July and 90% for August and September. ”
“President Trump has reached an extraordinary agreement to guarantee Americans access to the first medicine authorized for Covid-19“US Secretary of Health Alex Azar said.” As far as possible, we want to ensure that every American patient who needs remdesivir can receive it. The Trump administration is doing everything in our power to learn more about life-saving therapies for Covid-19 and to ensure that the American people have access to these options. ”
So the country would adopt an ‘America first’ approach in pandemic management, notes the British newspaper.
The issue also intervenedWorld Health Organization. “We must make sure that everyone has access to life-saving treatments like Remdesivir, we are committed to understanding the exact nature of the contract” for the supply of the anti-Covid-19 drug in the United States, they emphasize, “and in making licensing and production agreements for fair access to therapies like this“.
Concern has also been expressed by the European People’s Party that the US “has purchased almost all of the global stocks of Remdesivir”, which is a “promising drug to treat Covid-19”. “We must make all the necessary efforts for to give European patients access to therapies against Covid-19“emphasizes Peter Liese, German MEP of the CDU, doctor and spokesperson for the PPE group for Health.” I am in direct contact with the pharmaceutical company – continues Liese – which produces remdesivir and I told them that they should be fair to European patients if they want to have a good relationship with the EU in the future with their other drugs as well. “Gilead Sciences, the pharmaceutical company that produces Remdesivir, had assured Liese, according to the MEP reported last Friday, that the drug would be been available also “for European patients”.
RESERVED REPRODUCTION © Copyright Adnkronos.